A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma

NCT07099391 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Dara-RVd
DRUG: Tec-RVd

Sponsor

Memorial Sloan Kettering Cancer Center